798 related articles for article (PubMed ID: 27245636)
1. The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway.
Ciura S; Sellier C; Campanari ML; Charlet-Berguerand N; Kabashi E
Autophagy; 2016 Aug; 12(8):1406-8. PubMed ID: 27245636
[TBL] [Abstract][Full Text] [Related]
2. C9ORF72 is a GDP/GTP exchange factor for Rab8 and Rab39 and regulates autophagy.
Corbier C; Sellier C
Small GTPases; 2017 Jul; 8(3):181-186. PubMed ID: 27494456
[TBL] [Abstract][Full Text] [Related]
3. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death.
Sellier C; Campanari ML; Julie Corbier C; Gaucherot A; Kolb-Cheynel I; Oulad-Abdelghani M; Ruffenach F; Page A; Ciura S; Kabashi E; Charlet-Berguerand N
EMBO J; 2016 Jun; 35(12):1276-97. PubMed ID: 27103069
[TBL] [Abstract][Full Text] [Related]
4. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
Beckers J; Tharkeshwar AK; Van Damme P
Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058
[TBL] [Abstract][Full Text] [Related]
5. OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia.
Farhan SMK; Gendron TF; Petrucelli L; Hegele RA; Strong MJ
Am J Med Genet B Neuropsychiatr Genet; 2018 Jan; 177(1):75-85. PubMed ID: 29080331
[TBL] [Abstract][Full Text] [Related]
6. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
[TBL] [Abstract][Full Text] [Related]
7. The progress in
Jiang L; Zhang T; Lu K; Qi S
Small GTPases; 2022 Jan; 13(1):56-76. PubMed ID: 33663328
[TBL] [Abstract][Full Text] [Related]
8. A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy.
Yang M; Liang C; Swaminathan K; Herrlinger S; Lai F; Shiekhattar R; Chen JF
Sci Adv; 2016 Sep; 2(9):e1601167. PubMed ID: 27617292
[TBL] [Abstract][Full Text] [Related]
9. Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.
Lattante S; Millecamps S; Stevanin G; Rivaud-Péchoux S; Moigneu C; Camuzat A; Da Barroca S; Mundwiller E; Couarch P; Salachas F; Hannequin D; Meininger V; Pasquier F; Seilhean D; Couratier P; Danel-Brunaud V; Bonnet AM; Tranchant C; LeGuern E; Brice A; Le Ber I; Kabashi E;
Neurology; 2014 Sep; 83(11):990-5. PubMed ID: 25098532
[TBL] [Abstract][Full Text] [Related]
10. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72.
Zhu Q; Jiang J; Gendron TF; McAlonis-Downes M; Jiang L; Taylor A; Diaz Garcia S; Ghosh Dastidar S; Rodriguez MJ; King P; Zhang Y; La Spada AR; Xu H; Petrucelli L; Ravits J; Da Cruz S; Lagier-Tourenne C; Cleveland DW
Nat Neurosci; 2020 May; 23(5):615-624. PubMed ID: 32284607
[TBL] [Abstract][Full Text] [Related]
11. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders.
Boivin M; Pfister V; Gaucherot A; Ruffenach F; Negroni L; Sellier C; Charlet-Berguerand N
EMBO J; 2020 Feb; 39(4):e100574. PubMed ID: 31930538
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms of Neurodegeneration Related to
Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
[TBL] [Abstract][Full Text] [Related]
13. C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis.
Narain P; Gomes J; Bhatia R; Singh I; Vivekanandan P
Neurobiol Aging; 2017 Aug; 56():211.e9-211.e14. PubMed ID: 28527524
[TBL] [Abstract][Full Text] [Related]
14. TDP-43 levels in the brain tissue of ALS cases with and without
Yang Y; Halliday GM; Kiernan MC; Tan RH
Neurology; 2019 Nov; 93(19):e1748-e1755. PubMed ID: 31619481
[TBL] [Abstract][Full Text] [Related]
15. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
16. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
Tomiyama H
Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
[TBL] [Abstract][Full Text] [Related]
17. Two FTD-ALS genes converge on the endosomal pathway to induce TDP-43 pathology and degeneration.
Shao W; Todd TW; Wu Y; Jones CY; Tong J; Jansen-West K; Daughrity LM; Park J; Koike Y; Kurti A; Yue M; Castanedes-Casey M; Del Rosso G; Dunmore JA; Zanetti Alepuz D; Oskarsson B; Dickson DW; Cook CN; Prudencio M; Gendron TF; Fryer JD; Zhang YJ; Petrucelli L
Science; 2022 Oct; 378(6615):94-99. PubMed ID: 36201573
[TBL] [Abstract][Full Text] [Related]
18. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model.
Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C
Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504
[TBL] [Abstract][Full Text] [Related]
19. PTK2/FAK regulates UPS impairment via SQSTM1/p62 phosphorylation in TARDBP/TDP-43 proteinopathies.
Lee S; Jeon YM; Cha SJ; Kim S; Kwon Y; Jo M; Jang YN; Lee S; Kim J; Kim SR; Lee KJ; Lee SB; Kim K; Kim HJ
Autophagy; 2020 Aug; 16(8):1396-1412. PubMed ID: 31690171
[TBL] [Abstract][Full Text] [Related]
20. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways.
Blokhuis AM; Koppers M; Groen EJN; van den Heuvel DMA; Dini Modigliani S; Anink JJ; Fumoto K; van Diggelen F; Snelting A; Sodaar P; Verheijen BM; Demmers JAA; Veldink JH; Aronica E; Bozzoni I; den Hertog J; van den Berg LH; Pasterkamp RJ
Acta Neuropathol; 2016 Aug; 132(2):175-196. PubMed ID: 27164932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]